Unicycive Therapeutics Files 8-K
Ticker: UNCY · Form: 8-K · Filed: Jul 8, 2025 · CIK: 1766140
| Field | Detail |
|---|---|
| Company | Unicycive Therapeutics, Inc. (UNCY) |
| Form Type | 8-K |
| Filed Date | Jul 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Unicycive Therapeutics filed an 8-K on 7/7/25, likely with company updates.
AI Summary
On July 7, 2025, Unicycive Therapeutics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This 8-K filing signals that Unicycive Therapeutics, Inc. has made a regulatory submission, potentially containing important updates for investors regarding company events or financial information.
Risk Assessment
Risk Level: low — The filing is a standard 8-K, and the provided excerpt does not contain specific negative news or financial distress indicators.
Key Players & Entities
- Unicycive Therapeutics, Inc. (company) — Registrant
- July 7, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 4300 El Camino Real, Suite 210 (address) — Principal executive offices
- Los Altos, CA 94022 (address) — Principal executive offices
- (650) 351-4495 (phone_number) — Registrant's telephone number
FAQ
What specific "Other Events" are being reported by Unicycive Therapeutics, Inc. in this 8-K filing?
The provided excerpt of the 8-K filing does not detail the specific "Other Events" being reported, only that this item is included.
What is the significance of the "Financial Statements and Exhibits" item in this filing?
This item indicates that the filing includes or refers to financial statements and other exhibits, which could contain updated financial information or supporting documents for the reported events.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 7, 2025.
Where are Unicycive Therapeutics, Inc.'s principal executive offices located?
Unicycive Therapeutics, Inc.'s principal executive offices are located at 4300 El Camino Real, Suite 210, Los Altos, CA 94022.
What is the company's state of incorporation?
The company's state of incorporation is Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 8, 2025 regarding Unicycive Therapeutics, Inc. (UNCY).